A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.
Public ClinicalTrials.gov record NCT04104685. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of a Combination of 3% Minocycline and 0.3% Adapalene Topical Foam Formulation for the Treatment of Moderate-to-Severe Acne (Study FX2016 40)
Study identification
- NCT ID
- NCT04104685
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Vyne Therapeutics Inc.
- Industry
- Enrollment
- 446 participants
Conditions and interventions
Conditions
Interventions
- 0.3% Adapalene Foam Drug
- 3% Minocycline Foam Drug
- FCD105 Combination Product
- Vehicle Foam Other
Drug · Combination Product · Other
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 17, 2019
- Primary completion
- Feb 27, 2020
- Completion
- Mar 2, 2020
- Last update posted
- Feb 4, 2021
2019 – 2020
United States locations
- U.S. sites
- 35
- U.S. states
- 18
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Foamix Institution #134 | Bryant | Arkansas | 72022 | — |
| Foamix Institution #121 | Rogers | Arkansas | 72758 | — |
| Foamix Institution #106 | Encino | California | 91436 | — |
| Foamix Institution #103 | Fremont | California | 94538 | — |
| Foamix Institution #122 | Huntington Beach | California | 92647 | — |
| Foamix Institution #109 | Manhattan Beach | California | 90266 | — |
| Foamix Institution #132 | San Diego | California | 92123 | — |
| Foamix Institution #107 | Hialeah | Florida | 33016 | — |
| Foamix Institution #127 | Lake City | Florida | 32055 | — |
| Foamix Institution #101 | Miami | Florida | 33126 | — |
| Foamix Institution #135 | Miami Beach | Florida | 33162 | — |
| Foamix Institution #118 | Sanford | Florida | 32771 | — |
| Foamix Institution #120 | Sunrise | Florida | 33351 | — |
| Foamix Institution #128 | Tampa | Florida | 33607 | — |
| Foamix Institution #130 | New Albany | Indiana | 47150 | — |
| Foamix Institution #116 | Plainfield | Indiana | 46168 | — |
| Foamix Institution #123 | Louisville | Kentucky | 40241 | — |
| Foamix Institution #126 | Baton Rouge | Louisiana | 70809 | — |
| Foamix Institution #124 | New Orleans | Louisiana | 70115 | — |
| Foamix Institution #136 | Watertown | Massachusetts | 02472 | — |
| Foamix Institution #114 | Clinton Township | Michigan | 48038 | — |
| Foamix Institution #111 | Fridley | Minnesota | 55432 | — |
| Foamix Institution #102 | Las Vegas | Nevada | 89148 | — |
| Foamix Institution #115 | New York | New York | 10022 | — |
| Foamix Institution #108 | Stony Brook | New York | 11790 | — |
| Foamix Institution #104 | High Point | North Carolina | 27262 | — |
| Foamix Institution #133 | Gresham | Oregon | 97030 | — |
| Foamix Institution #125 | Johnston | Rhode Island | 02919 | — |
| Foamix Institution #119 | Mt. Pleasant | South Carolina | 29464 | — |
| Foamix Institution #110 | Arlington | Texas | 76011 | — |
| Foamix Institution #117 | College Station | Texas | 77845 | — |
| Foamix Institution #112 | Pflugerville | Texas | 78660 | — |
| Foamix Institution #105 | San Antonio | Texas | 78213 | — |
| Foamix Institution #131 | Layton | Utah | 84041 | — |
| Foamix Institution #113 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04104685, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 4, 2021 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04104685 live on ClinicalTrials.gov.